The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol
Authors:
Open Access
- 6 December 2022
- journal article
- research article
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 30, 101045
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasisMolecular Immunology, 2013
- Eight-weekly intravenous antibiotics is beneficial in severe bronchiectasisQJM: An International Journal of Medicine, 2012
- Non-cystic fibrosis bronchiectasisClinical Medicine, 2009
- Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasisEuropean Respiratory Journal, 2009
- Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis BronchiectasisChest, 2007
- A Pilot Study of the Safety and Efficacy of Tobramycin Solution for Inhalation in Patients With Severe Bronchiectasis*Chest, 2005
- Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'Nature Reviews Microbiology, 2004
- Intermittent Administration of Inhaled Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1999
- Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasisJournal of Antimicrobial Chemotherapy, 1994
- Sample size for Poisson regressionBiometrika, 1991